Drug General Information (ID: DDIHLB04VN)
  Drug Name Enoxacin Drug Info Methotrexate Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiinfective Agents Antimetabolites
  Structure

 Mechanism of Enoxacin-Methotrexate Interaction (Severity Level: Moderate)
     Competitive inhibition of renal tubular secretion Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Enoxacin Methotrexate
      Mechanism Competitive inhibition of renal tubular secretion of methotrexate Methotrexate
      Key Mechanism Factor 1
Factor Name Renal tubular secretion
Factor Description Renal tubular secretion allows selective transfer of substances from the blood around the capillaries into the renal tubules via filtrate. Drug excretion may be reduced when two drugs compete for renal tubular secretion.
      Mechanism Description
  • Decreased elimination of Methotrexate caused by Enoxacin mediated competitive inhibition of renal tubular secretion

Recommended Action
      Management Caution is advised if quinolones must be used with methotrexate. The authors of the case report recommend that ciprofloxacin and related antibiotics not be coadministered with high-dose methotrexate. During concomitant use, patients should be monitored for altered pharmacologic effects of both drugs and the dosage(s) adjusted accordingly if necessary.

References
1 Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
2 Nesher G, Mates M, Zevin S "Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis." Arthritis Rheum 48 (2003): 571-572. [PMID: 12571869]
3 Dalle JH, Auvrignon A, Vassal G, Leverger G "Interaction Between Methotrexate and Ciprofloxacin." J Pediatr Hematol Oncol 24 (2002): 321-322